1. |
Bladin CF, Alexandrov AV, Bellavance A, et al. Seizures after stroke:a prospective multicenter study. Arch Neurol, 2000, 57(11): 1617-1622.
|
2. |
Labovitz DL, Hauser WA, Sacco RL. Prevalence and predictors of early seizure and status epilepticus after first stroke. Neurology, 2001, 57(2): 200-206.
|
3. |
Annegers JF, Hauser WA, Lee JR, et al. Incidence of acute symptomatic seizures in Rochester, Minnesota, 1935-1984. Epilepsia, 1995, 36(4):327-333.
|
4. |
Forsgren L, Bucht G, Eriksson S, et al. Incidence and clinical characterization of unprovoked seizures in adults:a prospective population-based study. Epilepsia, 1996, 37(2):224-229.
|
5. |
Arboix A, Comes E, Massons J, et al. Relevance of early seizures for in-hospital mortality in acute cerebrovascular disease. Neurology, 1996, 47(8):1429-1435.
|
6. |
Burneo JG, Fang J, Saposnik G. Investigators of the Registry of the Canadian Stroke N. Impact of seizures on morbidity and mortality after stroke:a Canadian multi-centre cohort study. Eur J Neurol, 2010, 17(5):52-58.
|
7. |
Drake C, Boutin H, Jones MS, et al. Brain inflammation is induced by co-morbidities and risk factors for stroke. Brain Behav Immun, 2011, 25(6):1113-1122.
|
8. |
Wang Z, Hoy WE. C-reactive protein and the risk of developing type 2 diabetes in aboriginal australians. Diabetes Res Clin Pract, 2007, 76(12):37-43.
|
9. |
Ishikawa N, Kobayashi Y, Fujii Y, et al. Increased interleukin-6 and high-sensitivity C-reactive protein levels in pediatric epilepsy patients with frequent, refractory generalized motor seizures. Seizure, 2015, 25(11):136-140.
|
10. |
Alapirtti T, Waris M, Fallah M, et al. C-reactive protein and seizures in focal epilepsy:a video-electroencephalographic study. Epilepsia, 2012, 53(7):790-796.
|
11. |
Beghi E, D'Alessandro R, Beretta S, et al. Incidence and predictors of acute symptomatic seizures after stroke. Neurology, 2011, 77(20):1785-1793.
|
12. |
Corso G, Bottacchi E, Brusa A, et al. Is there a prognostic role for C-reactive protein in ischemic stroke? Acta Neurol Scand, 2010, 122(3):209-216.
|
13. |
den Hertog HM, van Rossum JA, van der Worp HB, et al. C-reactive protein in the very early phase of acute ischemic stroke:association with poor outcome and death. J Neurol, 2009, 256(5):2003-2008.
|
14. |
Rajeshwar K, Kaul S, Al-Hazzani A, et al. C-reactive protein and nitric oxide levels in ischemic stroke and its subtypes:correlation with clinical outcome. Inflammation, 2012, 35(3):978-984.
|
15. |
Vezzani A, Aronica E, Mazarati A, et al. Epilepsy and brain inflammation. Exp Neurol, 2013, 244(6):11-21.
|
16. |
Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages:implications for atherosclerosis. Circulation, 2001, 103(9):1194-1197.
|
17. |
Winbeck K, Poppert H, Etgen T, et al. Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke, 2002, 33(10):2459-2464.
|
18. |
Mintzer S, Skidmore CT, Abidin CJ, et al. Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein. Ann Neurol, 2009, 65(4):448-456.
|